Page last updated: 2024-08-21

thymoquinone and Leukemia, Promyelocytic, Acute

thymoquinone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Al-Jamal, HAN; Almajali, B; Doolaanea, AA; Ibrahim, WN; Ismail, I; Johan, MF; Tajudin, SA; Wan Taib, WR	1

Other Studies

1 other study(ies) available for thymoquinone and Leukemia, Promyelocytic, Acute

Article	Year
Thymoquinone Suppresses Cell Proliferation and Enhances Apoptosis of HL60 Leukemia Cells through Re-Expression of JAK/STAT Negative Regulators. Asian Pacific journal of cancer prevention : APJCP, 2021, Mar-01, Volume: 22, Issue:3 Topics: Apoptosis; Benzoquinones; Cell Proliferation; HL-60 Cells; Humans; Inhibitory Concentration 50; Janus Kinases; Leukemia, Promyelocytic, Acute; Protein Tyrosine Phosphatase, Non-Receptor Type 6; STAT Transcription Factors; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein	2021

Article

Year

Thymoquinone Suppresses Cell Proliferation and Enhances Apoptosis of HL60 Leukemia Cells through Re-Expression of JAK/STAT Negative Regulators.

Asian Pacific journal of cancer prevention : APJCP, 2021, Mar-01, Volume: 22, Issue:3

Topics: Apoptosis; Benzoquinones; Cell Proliferation; HL-60 Cells; Humans; Inhibitory Concentration 50; Janus Kinases; Leukemia, Promyelocytic, Acute; Protein Tyrosine Phosphatase, Non-Receptor Type 6; STAT Transcription Factors; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling 3 Protein

2021